WatchBP Home A
Manufacturer: Microlife WatchBP
Product ID: MIC-HOME A
AF is the most common sustained cardiac arrhythmia occurring in 5% of the population older than 65 years of age and in 14% among those older than 85 years. AF leads to a 5-fold higher risk of stroke and is responsible for 20% of all strokes. Many people have no symptoms from AF and therefore remain undiagnosed, whereas early treatment can reduce the risk of stroke by 68%.
WatchBP AFIB monitors allow AF screening during blood pressure measurement. The AF detection system has proven its accuracy, and leads to detection of more new patients with AF when used in general clinical practice.
Three consecutive measurements in a row
Guidelines recommend taking at least two blood pressure readings each time and average the measurements.
Advantages of taking 3 consecutive measurements:
• More accurate blood pressure measurement.
• Three sequential measurements diminishes the influence of a single deviating (high) reading.
Transmit measurement data to PC via USB connection.
The software for all WatchBP devices is user friendly and allows easy data transfer and analysis. WatchBP software is free of charge to download direct from our website onto your computer.
Validated blood pressure monitors for patients with end-stage renal disease.
Patients with renal disease have a very high incidence of hypertension, paired with stiff (calcified) arteries. As automated measurements are often inaccurate in patients with stiff arteries, a special validation is required.
Accurate measurement for patients with Diabetes.
Microlife blood pressure monitors are validated for blood pressure measurement in patients with diabetes. Patients with Diabetes Mellitus type 1 and 2 may have stiff arteries that can affect the blood pressure measurement. A recent validation study in diabetes patients type 1 and 2 showed that the Microlife monitor is accurate when used in this patient group.
Accurate measurement for children 12-18 years
All automatic upper arm blood pressure monitors of Microlife and WatchBP Home series can be recommended for children and adolescents aged 12 to 18 years old.
“WatchBP Home A should be used for hypertension monitoring in primary care”
The National Institute for Health and Care Excellence (NICE) officially recommends using the WatchBP Home A during routine blood pressure measurement for all GP’s in the United Kingdom.
The National Institute for Health and Care Excellence (NICE) officially recommends using the WatchBP Home A during routine blood pressure measurement for all GP's in the United Kingdom.